The pharmaceutical industry is a major player in the life science sector, responsible for developing and manufacturing the majority of…
Stock is trading at $28 compared with Eli Lilly’s $739 price tag. That could change if a trial of a…
…
Heres what could happen to Eli Lillys shares next.…
Troubled regional bank New York Community Bank faced a downgrade from JPMorgan, while Pharma giant Eli Lilly was the beneficiary…
…
LLY earnings call for the period ending December 31, 2023.…
Eli Lilly (LLY) shares were down slightly Tuesday despite reporting better-than-expected earnings on both the top and bottom lines for…
…
Its not a surprise to see traders taking profits in Eli Lilly on Tuesday. But we have no intention of…
Novo Nordisk and Eli Lilly are working to increase supply of their popular weight loss drugs. Meanwhile, the implantable neurotechnology…
…
The results add to a long list of potential health benefits of tirzepatide besides helping patients shed significant pounds and…
Pharma giant Eli Lilly and Co said expects revenues to grow by 18% in 2024 to more than $40 billion with…
…
Premarket movers: Eli Lilly, NXP rises; Chegg dips…
INDIANAPOLIS (dpa-AFX) - Nach dem Verkaufsstart seines Abnehmmittels traut sich der Pharmakonzern Eli Lilly 2024…
These are the stocks posting the largest moves in premarket trading.…
Das Pharmaunternehmen Eli Lilly hat neue Zahlen für das vierte Quartal 2023 veröffentlicht und einen Ausblick auf dieses Jahr gegeben.…
Other key earnings movers include Eli Lilly, Spotify and Vertex Pharmaceuticals.…
INDIANAPOLIS (dpa-AFX) - Nach dem Verkaufsstart seines Abnehmmittels traut sich der Pharmakonzern Eli Lilly 2024…
Zepbound, which contains the active ingredient tirzepatide, is expected to become one of the best selling drugs of all time.…
Eli Lilly Scored a strong Q4 win and provided healthy guidance Tuesday. Shares moved toward a profit-taking zone following a…
Eli Lillys market value is more than $100 million north of Teslas.…
…
7:00am: Modest falls expected; Eli Lilly jumps on earnings beat Stock futures in New York edged lower on Tuesday as…
9:45am: Stocks start Tuesday on the front foot Stocks made steady progress when trading began on Tuesday boosted by gains…
…
…
Eli Lilly beats profit forecast amid soaring weight-loss drug demand…
The quarterly results are the first to include sales of Eli Lillys new weight loss drug Zepbound, which won FDA…
Eli Lilly earnings beat by $0.18, revenue topped estimates…
Eli Lilly earnings ahead, Toyota lifts annual guidance - whats moving markets…
Eli Lilly (LLY) beats fourth-quarter estimates for earnings as well as sales. The company issues an upbeat guidance for 2024.…
…
Third Bridge, Global Sector Lead: Health Care, Lee Brown to discuss the big movers on the back of analyst recommendations…
Growth may slow, and its valuation is looking precarious.…
Growth may slow, and its valuation is looking precarious.…
Eli Lilly, Danaher, Citigroup, Shopify and Canadian Pacific Kansas are included in this Analyst Blog.…
Its drug tirzepatide showed top efficacy as a weight-loss treatment according to the latest real-world data.…
…
Its drug tirzepatide showed top efficacy as a weight-loss treatment according to the latest real-world data.…
Drug and biotech companies are likely to see significant innovation. In the Large-Cap Pharmaceuticals industry, Eli Lilly (LLY), Novo Nordisk…
Todays Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), Danaher Corporation (DHR)…
The positive response to anti-obesity drugs has put Eli Lilly and Novo Nordisk in the spotlight.…
One of its more recently approved drugs will be launched into a white-hot market.…
On Eli Lillys (LLY) fourth-quarter conference call, investor focus is likely to be on the sales performance of its tirzepatide…
…
Eli Lilly is the worlds largest healthcare company by market cap, and the 10th most valuable business in the world.…
Eli Lilly has a dual-track approach to make more of its fast-growing diabetes and obesity drugs.…